NDC 17856-2170 – Acyclovir suspension
Acyclovir 200 mg/5mL · Suspension · Oral
Product NDC17856-2170
Product details
- Brand name
- Acyclovir suspension
- Generic name
- Acyclovir
- Labeler
- Atlantic Biologicals Corp.
- Dosage form
- Suspension
- Route
- Oral
- Marketing category
- ANDA · ANDA217393
- Marketed since
- March 9, 2023
- Listing expires
- December 31, 2027
- Pharmacologic class
- Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor
Active ingredients
- Acyclovir 200 mg/5mL
Uses, dosage, side effects and warnings for Acyclovir suspension →
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 17856-2170-1 | 72 CUP, UNIT-DOSE in 1 CASE (17856-2170-1) / 5 mL in 1 CUP, UNIT-DOSE | May 4, 2026 |
| 17856-2170-2 | 72 CUP, UNIT-DOSE in 1 CASE (17856-2170-2) / 10 mL in 1 CUP, UNIT-DOSE | May 4, 2026 |
Other Acyclovir suspension products
- 72205-170 Acyclovir 200 mg/5mL · Suspension · Novadoz Pharmaceuticals LLC